Dalotuzumab (IGF1R/CD221) - Research Grade Biosimilar
Product Specifications
Background
Dalotuzumab has been investigated for the treatment of Breast Cancer, Non Small Cell Lung Cancer, and Metastatic Colorectal Cancer.
Immunogen
Humanized / IGF1R/CD221 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
MK-0646
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1013510-01 1 mg (E-Coli)
Recombinant Yersinia pseudotuberculosis serotype O:1b Na (+)/H (+) antiporter nhaA, partial
Sign In for Pricing
View Details MBS1013510-02 1 mg (Yeast)
Recombinant Yersinia pseudotuberculosis serotype O:1b Na (+)/H (+) antiporter nhaA, partial
Sign In for Pricing
View Details 
ELK7199-01 48 Tests
Rat PAR1 (Protease Activated Receptor 1) ELISA Kit
Sign In for Pricing
View Details